Xenon Pharmaceuticals Inc (XENE)
40.53
-1.91
(-4.50%)
USD |
NASDAQ |
May 10, 13:57
Xenon Pharmaceuticals Accounts Receivable (Quarterly): 0.874M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.874M |
September 30, 2023 | 0.805M |
June 30, 2023 | 2.123M |
March 31, 2023 | 2.222M |
December 31, 2022 | 0.986M |
September 30, 2022 | 2.482M |
June 30, 2022 | 2.524M |
March 31, 2022 | 2.923M |
December 31, 2021 | 2.765M |
September 30, 2021 | 3.235M |
June 30, 2021 | 2.919M |
March 31, 2021 | 5.06M |
December 31, 2020 | 1.822M |
September 30, 2020 | 1.609M |
June 30, 2020 | 1.786M |
March 31, 2020 | 1.617M |
December 31, 2019 | 0.813M |
September 30, 2019 | 0.209M |
June 30, 2019 | 0.171M |
March 31, 2019 | 0.132M |
Date | Value |
---|---|
December 31, 2018 | 0.151M |
September 30, 2018 | 0.18M |
June 30, 2018 | 0.171M |
March 31, 2018 | 0.432M |
December 31, 2017 | 0.438M |
September 30, 2017 | 0.129M |
June 30, 2017 | 0.198M |
March 31, 2017 | 0.189M |
December 31, 2016 | 0.20M |
September 30, 2016 | 0.595M |
June 30, 2016 | 0.658M |
March 31, 2016 | 0.386M |
December 31, 2015 | 0.315M |
September 30, 2015 | 0.274M |
June 30, 2015 | 0.188M |
March 31, 2015 | 1.205M |
December 31, 2014 | 0.215M |
September 30, 2014 | 0.162M |
June 30, 2014 | 0.364M |
December 31, 2013 | 0.44M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.171M
Minimum
Jun 2019
5.06M
Maximum
Mar 2021
1.944M
Average
1.822M
Median
Dec 2020
Accounts Receivable (Quarterly) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 24.09M |
Edesa Biotech Inc | 0.7436M |
Lexaria Bioscience Corp | -- |
ESSA Pharma Inc | 0.1806M |